Skip to content
Kalpvruksh Markets
Offline Log in

ANTHEMNSEOffline

ANTHEM BIOSCIENCES · INE0CZ201020 · Mid Cap · #230
913.55+25.25 (+2.84%)last close · 05 Nov 2026
Prev close
888.30
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹39,540 cr
52-week range · to 05 Nov 2026592.4957.8

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

ANTHEM is 5% below its 52-week high, above its 200-day average, ahead of Healthcare by 9.6 pts over 3 months — a Mid Cap company, #230 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50 / 200-day averages · 5% below its 52-week high
  • ahead of its industry by 9.6 pts over 3 months · rank 18 of 44 in Healthcare · +13.1% vs Nifty 500
  • traded value 1.0× usual · delivery 52% vs 55% usual
  • FPI +1.2 pp · DII −1.4 pp · MF schemes in Sept 2026: 60 bought, 28 cut · no promoter pledge · quarter ended 2026-09-30
  • Jun 2026 quarter: profit −12% year on year · revenue −23%
  • ftse large_mid: add candidate (2027-03)

How big is it?

six-month average market cap

Market capitalisation
₹39,540 cr
Rank
#230
Cap band
Mid Cap
Nearest cut-off — Mid / Small
+15.65% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.4×
median 2,82,179
Delivered
3,91,458
Of volume
54%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+10.0%+4.0 pts—
1 month+2.6%−1.9 pts−1.3 pts
3 months+10.6%+13.1 pts+9.6 pts
6 months+18.8%+18.4 pts+7.2 pts
1 year+27.4%+30.7 pts—

Industry: Healthcare (Nifty 500 classification) · rank 18 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+8.3%
above
vs 50-day average
+3.6%
above
vs 200-day average
+18.4%
above
ATR (14)
3.1%
typical daily range
Volatility
30%
1 month, annualised
Beta
0.62
vs Nifty 500, 1 year
Traded value
1.0×
vs usual
Delivery
52%
usual 55%
From the 52-week high
−4.6%
place in range 88% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters74.7%74.7%71.4% −3.371.4%
FPI1.4%1.3% −0.12.6% +1.33.8% +1.2
Mutual funds6.9%10.1% +3.211.2% +1.09.3% −1.9
Other DII0.7%1.4% +0.72.3% +0.92.8% +0.5
Individuals9.6%9.4% −0.29.4% +0.19.5%
Others6.7%3.1% −3.63.1%3.2% +0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Sep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
1,76,209
Individuals
1,69,169

Indian passive funds’ stake

2026-06-30

Of free float
0.30%
Of all shares
0.09%
Schemes
65
Days to unwind
0.6
at 100% of volume

4,87,007 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
148
65 index · 83 active
Bought more
77
Sold some
15
FundSharesChangeDid
Mahindra Manulife Flexi Cap Fund-Reg(G)Active+1,58,086+395.2%bought
360 ONE Flexicap Fund-Reg(G)Active+3,60,186+232.1%bought
WOC Pharma and Healthcare Fund-Reg(G)Active+74,769+216.6%bought
HSBC Midcap Fund-Reg(G)Active−24,55,671−79.5%sold
SBI Quality Fund-Reg(G)Active−3,23,413−49.9%sold
Axis Business Cycles Fund-Reg(G)Active−1,52,293−46.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26128654235−6.9%₹3,801 cr
Aug 261271060135−0.2%₹4,247 cr
Jul 26122742255−12.2%₹3,856 cr
Jun 26120186347+10.9%₹4,182 cr
May 26109039241−3.3%₹3,720 cr
Apr 26110449141−1.4%₹3,846 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
Bought ₹0 (0)
Sold ₹82.67 cr (1)
Latest 2 of 4 disclosures
0 selected
09 Mar 2026Krithika GaneshPromoter GroupSell85,57,302₹00.00%Gift
09 Mar 2026Aruna GaneshPromoter GroupBuy85,57,302₹03.05%Gift

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Anthem Biosciences Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the period ended September 30, 2026.
    04 Nov 2026
  • Board outcome
    Anthem Biosciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    21 Jul 2026
  • Takeover (SAST)
    Anthem Biosciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    06 Jul 2026
  • Credit rating
    Anthem Biosciences Limited has informed the Exchange about Credit Rating
    03 Jul 2026
  • Bulk deal: SELL
    1,71,14,604 at ₹744.8 — ARUNA GANESH
    18 Jun 2026
  • Block deal: BUY
    3,35,661 at ₹744.8 — 360 ONE MUTUAL FUND
    18 Jun 2026
  • Block deal: SELL
    1,71,14,604 at ₹744.8 — ARUNA GANESH
    18 Jun 2026
  • Block deal: BUY
    12,08,379 at ₹744.8 — BAJAJ LIFE INSURANCE LIMITED
    18 Jun 2026

Latest shown; 9 in six months on all disclosures.

ANTHEM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹2Final25 Jun 202626 Jun 2026

1 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.